SUMMARY In order to study left ventricular diastolic function in diabetes mellitus, simultaneous echo-and phonocardiograms were recorded in 142 diabetics (free from heart disease), 20 8 October 1981 Patients and methods Patients and control subjects have previously been described in detail.' 2 From 473 diabetics, aged 16 to 60 years, 185 were selected as free from clinical heart disease, hypertension (diastolic blood pressure above 100 mmHg), and conditions known to influence left ventricular function. Of these, 142 had echocardiograms which were suitable for the computerised analysis (79 men and 63 women, mean age 41+9 years); 42 of these were insulin-dependent diabetics who developed the disease before the age of 20 in whom the clinical presentation of diabetes was assumed to represent its onset. These 42 patients were used to determine relations to the duration of diabetes (mean duration of diabetes 9±8 years, range 0 to 25 years).
Impaired left ventricular function may frequently be detected in asymptomatic diabetics.' It is related to the presence and extent of diabetic microvascular complications and the duration of diabetes, and is presumably the result of specific diabetic myocardial involvement.2 Although systolic time intervals are abnormal in some diabetics,'-5 they have a complex underlying mechanism and are more frequently abnormal in diabetics with associated disorders such as hypertension, coronary artery disease, and heart failure. ' The studies of Sanderson et al. 6 and Shapiro et al. 12 5 suggest that impairment of some aspects of diastolic function is common and may be the primary abnormality in diabetes; the purpose of the present paper is to extend previous studies of diastolic left ventricular function by detailed examination of relaxation, cavity filling, and wall thinning using computerised interpretation of manually digitised ecaocardiograms.
*Present address: Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 OHS. Accepted for publication 8 October 1981 Patients and methods Patients and control subjects have previously been described in detail. ' 2 From 473 diabetics, aged 16 to 60 years, 185 were selected as free from clinical heart disease, hypertension (diastolic blood pressure above 100 mmHg), and conditions known to influence left ventricular function. Of these, 142 had echocardiograms which were suitable for the computerised analysis (79 men and 63 women, mean age 41+9 years); 42 of these were insulin-dependent diabetics who developed the disease before the age of 20 in whom the clinical presentation of diabetes was assumed to represent its onset. These 42 patients were used to determine relations to the duration of diabetes (mean duration of diabetes 9±8 years, range 0 to 25 years).
The 142 diabetics were subdivided into the following groups:
(i) Diabetics with no complications (n=39).
(ii) Diabetics with mild microvascular complications, mild background retinopathy, and/or mild proteinuria (n=47). 439 Shapiro (iii) Diabetics with severe microvascular complications, heavy proteinuria, and/or proliferative retinopathy (n=44).
(iv) Recently diagnosed (within three years) young insulin-dependent diabetics (n= 12) .
The 142 diabetics were graded according to the presence and extent of complications and an index of microvascular complications was constructed by summation of the individual scores for each complication subgroup (Table 1) which allowed for a scale from zero (with no complications, as in groups (i) and (iv)) to seven (when all were present and severe as in some patients in group (iii)). (Fig. 1 ).
Echocardiographs were digitised as previously described by Gibson and (Fig. 2) .
(1) End-diastolic (R wave electrocardiogram) posterior wall thickness (cm).
(2) Peak rate of change of posterior wall thickness in early diastole8 (cnmls). Difference between subjects with coronary artery disease and diabetes: ttp<0-001; § §p<0-01. (Table 4) .
Discussion
Computerised interpretation of the M-mode echocardiogram is an excellent way of studying left ventricular diastolic function because of an unequivocal identification of the epi-and endocardial surfaces and mitral valve opening.7 9 The timing of aortic valve closure represented by A2 was normal in healthy subjects and most diabetics. Mitral valve opening was significantly delayed relative to minimum dimension in most diabetics, and this was the result of prolonged isovolumic relaxation. Both were strongly correlated with the microvascular complications index and duration of diabetes' 6 and, as expected, only young diabetics were normal. Such findings are, however, not specific to diabetes and have been described in other cardiac disorders,71 and are the result of disturbed ventricular relaxation.
In subjects with coronary artery disease and in diabetics with incoordinate relaxation, mitral valve opening was also delayed relative to minimum dimension, but isovolumic relaxation time was only slightly Significances: tp<O-OO1; Sp<001; ¶NS.
prolonged. In this situation it has been shown that though the timing of A2 is normal, minimum dimension occurs relatively early because of incoordinate systolic wall motion, accompanied by increase in cavity dimension before mitral valve opening, because of incoordinate relaxation.8Y'0 Seventy-eight per cent of diabetics and all normal controls showed no significant change of dimension during isovolumic relaxation. There was, however, a wide range of values for dimension change during isovolumic relaxation and 15% (3 SD from normal) arbitrarily defined incoordinate relaxation. This is found in coronary artery disease and other left ventricular diseases and is usually explained by segmental abnormalities of relaxation.9 Incoordinate relaxation was found in 31 diabetics but there was no trend towards greater dimension change with increasing severity of microvascular complications. While the incoordination may be the result of microvascular disease with patchy fibrosis impairing regional myocardial function, it is more likely that the cause is asymptomatic but significant coronary artery stenosis, especially as similar abnormalities have been noted in diabetics with angina. ' In diabetics with severe complications delayed mitral valve opening was accompanied by prolonged duration and reduced rate of dimension increase, and these abnormalities were closely correlated with the extent of microvascular complications. In diabetics with severe complications the pattern of increase in cavity dimension was similar to that described in mitral7 and aortic valve stenosis, and hypertrophic cardiomyopathy and severe hypertension. " The abnormal filling in mitral stenosis is caused by inflow-tract obstruction, but in aortic stenosis, hypertrophic cardiomyopathy, and hypertension the abnormal filling and relaxation is caused by the altered properties of the hypertrophied ventricle.8 11 Similarly, in diabetics the pattern of slow and prolonged increase in dimension was not the result of haemodynamic factors, and was totally unlike the asynchronous abnormalities with essentially normal filling in coronary artery disease.
In diabetics wall thickness was normal. In those subjects with severe complications the peak rate of wall thinning was reduced and prolonged in a manner similar to dimension increase; these abnormalities, similar to those found in the hypertrophied myocardium,8 were correlated to duration of diabetes and microvascular complications. In coronary artery disease rapid wall thinning is normal.8 Within the subgroup of diabetics with incoordinate relaxation there was a wide range of rates and durations of thinning and increase in dimension, which could also be correlated with the clinical features of diabetes. Therefore, impairment of wall thinning and dimension increase must be the result of abnormal properties of myocardium, which are independent of, and can coexist with, segmental abnormalities of arterial supply. Diabetics, especially those with severe microvascular complications, have small vessel involvement of the coronary microcirculation analogous to that in the retina and kidney.'2-'5 Capillary microaneurysms, basement membrane thickening, and endothelial proliferation have been described in necropsy and biopsy studies. These small vessel abnormalities ultimately induce diffuse myocardial ischaemia, with resultant extracellular fibrosis. Experimental evidence in dogs rendered diabetic with alloxan suggests that myocardial glycoprotein deposition can impair the left ventricular end-diastolic pressure/volume ratio. 3 These pathological changes would disrupt the active processes which determine changes in myocardial properties that are responsible for relaxation and filing. '6 This would readily explain the impaired wall thinning. The role of diffuse ischaemia is uncertain as myocardial cells have a normal structure'3 but may well be important in impairing function.
"Heart failure" and "cardiomyopathy" have been attributed by some authors to diabetes in subjects with recently diagnosed or uncomplicated diabetes or an impaired glucose tolerance test.15 From this and previous studies,1 2 it is clear that there is a graded response in left ventricular function to the severity of diabetes; in general only subjects with severe microvascular complications had impaired wall thinning, and heart failure usually only occurred in diabetics with severe complications and was often associated with hypertension.' It is, therefore, unlikely that specific diabetic heart disease is responsible for heart failure in subjects with mild diabetes who would not be expected to have coronary microangiopathy, though such patients do have impaired relaxation; this may well explain the increased mortality occurring after myocardial infarction.
The present echocardiographic study shows that in diabetes, though the myocardium is not hypertrophied it has similar properties to those found in myocardial hypertrophy with abnormal relaxation and wall thinning. This supports haemodynamic and histological studies which show that in diabetes there is an intrinsic abnormality of myocardium.
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